Resources
Nanopharm Resources
As a leader in the field of developing and testing nasal and inhaled drug delivery products, Nanopharm is committed to advancing scientific knowledge in this specialized area. Our team of dedicated scientists conduct cutting-edge research, and we are excited to share our content with you. By sharing our scientific publications webinars and white papers, we aim to foster a spirit of collaboration, inspire new ideas, and contribute to the collective knowledge of the OINDP scientific community. We encourage you to explore our resources page but please visit this section at regular intervals as our team continues to share the latest scientific articles with you.
11 February 2025
Advancing Alternative Bioequivalence for OINDPs
Bioequivalence, Nanopharm, OINDPs
Filter Resources By
14 Apr 2022
Biologics, drug delivery, Drug Development, Nanopharm, Nasal, SARS-CoV-2
06 Apr 2022
environmental footprint, Global Warming Potential, MDIs, metered dose inhalers, SmartTrack
01 Apr 2022
Aptar Pharma, drug delivery, Nasal
09 Dec 2021
Biologics Characterization, cGMP, Drug Development, Nanopharm, OINDP, Particle Engineering
09 Dec 2021
Dry powder inhaler, Fluticasone Propionate, Inhalation
03 Nov 2021
Aerodynamic, Antigen, Dry Powder, GLA, Human Papillomavirus, Inhalation, Nanopharm, Performance, Vaccine
06 Oct 2021
Global Warming Potential, Inhalation, pMDI
21 Jul 2021
Drug Development, Intranasal Spray, Leyden Labs, Nanopharm, OINDP, Respiratory Viruses
30 Mar 2021
Nasal, Nasal Suspension Drug, Raman Spectroscopy
